A review on metastatic breast cancer in Iran

作者: Hamidreza Alizadeh Otaghvar , Mostafa Hosseini , Adnan Tizmaghz , Ghazaal Shabestanipour , Hamid Noori

DOI: 10.1016/J.APJTB.2015.02.001

关键词:

摘要: Abstract Metastatic breast cancer is a disease of early that usually occurs several years after the cancer. Breast most common among Iranian women. According to new statistics in Iran 6160 cancers are diagnosed country each year and 1063 cases lead death. In this paper, epidemiology, diagnosis treatment have been investigated. study, case–control clinical trials open studies with adequate data were collected. Due higher risk age group 40–49 advent advanced women, determination exact size tumor before surgery important choosing therapy plan. The decision on invasive depends factors such as stage, type, pathological cytological status tumor, patient's opinion, presence or absence estrogen progesterone receptors cytoplasm cells so on.

参考文章(77)
Marcia Grant, Shirley Otis-Green, Brandi Funk, Betty R. Ferrell, Nellie Garcia, Michelle L.J. Schaffner, Quality of life in breast cancer. Cancer Practice. ,vol. 4, pp. 331- 340 ,(1996)
Robert W Carlson, Elizabeth Brown, Harold J Burstein, William J Gradishar, Clifford A Hudis, Charles Loprinzi, Eleftherios Paul Mamounas, Edith A Perez, Kathleen Pritchard, Peter Ravdin, Abram Recht, George Somlo, Richard L Theriault, Eric P Winer, Antonio C Wolff, None, NCCN Task Force Report: Adjuvant Therapy for Breast Cancer. Journal of The National Comprehensive Cancer Network. ,vol. 4, ,(2006) , 10.6004/JNCCN.2006.2001
Csaba Gajdos, Paul I Tartter, Ira J Bleiweiss, Carol Bodian, Steven T Brower, Stage 0 to stage III breast cancer in young women. Journal of The American College of Surgeons. ,vol. 190, pp. 523- 529 ,(2000) , 10.1016/S1072-7515(00)00257-X
Michael W. DeGregorio, Tamoxifen and Breast Cancer ,(1994)
A. Sue Brown, Kenneth Brummel-Smith, Lavola Burgess, Ralph B. D'Agostino, John W. Goldschmidt, Jeffrey B. Halter, William R. Hazzard, Dennis W. Jahnigen, Charles Phelps, Murray Raskind, Robert W. Schrier, Harold C. Sox, Sankey V. Williams, May Wykle, National Institutes of Health Consensus Development Conference Statement: Geriatric Assessment Methods for Clinical Decision-making Journal of the American Geriatrics Society. ,vol. 36, pp. 342- 347 ,(1988) , 10.1111/J.1532-5415.1988.TB02362.X
Ian M. Holdaway, Barbara H. Mason, Lye H. Yee, Ronald G. Kay, Peter R. Mullins, Progesterone and Estrogen Receptors as Prognostic Variables in Breast Cancer Cancer Research. ,vol. 43, pp. 2985- 2990 ,(1983)
Kenji Shibuya, Colin D Mathers, Cynthia Boschi-Pinto, Alan D Lopez, Christopher JL Murray, None, Global and regional estimates of cancer mortality and incidence by site: II. results for the global burden of disease 2000 BMC Cancer. ,vol. 2, pp. 37- 37 ,(2002) , 10.1186/1471-2407-2-37
M N Levine, V H Bramwell, K I Pritchard, B D Norris, L E Shepherd, H Abu-Zahra, B Findlay, D Warr, D Bowman, J Myles, A Arnold, T Vandenberg, R MacKenzie, J Robert, J Ottaway, M Burnell, C K Williams, D Tu, Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology. ,vol. 16, pp. 2651- 2658 ,(1998) , 10.1200/JCO.1998.16.8.2651